Mal-PEG4-VC-PAB-DMEA (TFA)

• UNSPSC Description:

  Mal-PEG4-VC-PAB-DMEA TFA is a degradable ADC linker containing a maleimide group and can be used to synthesize antibody conjugate active molecules (ADCs)[1].

• Target Antigen:

  ADC Linker

• Type:

  Reference compound

• Related Pathways:

  Antibody-drug Conjugate/ADC Related

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/mal-peg4-vc-pab-dmea-tfa.html

• Smiles:

  O=C(C=CC1=O)N1CCC(NCCOCCOCCOCCOCCC(N[C@@H](C(C)C)C(N[C@@H](CCCNC(N)=O)C(NC(C=C2)=CC=C2COC(N(C)CCNC)=O)=O)=O)=O)=O.O=C(O)C(F)(F)F

• Molecular Weight:

  1006.03

• References & Citations:

  [1] Italo Beria, et al. New alkylating agents. WO2013149948A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported